BioNTech SE - ADR BNTX and Moderna Inc MRNA shares are trading lower Tuesday morning in sympathy with Pfizer Inc. PFE after the company issued FY23 guidance below estimates. Also, the Biden Administration said it plans to end COVID-19 emergency declarations on May 11.
See Also: Biden Administration Plans To End COVID-19 Public Health Emergency In May
Pfizer's FY23 Outlook
Pfizer forecasts FY23 sales to fall to $67-$71 billion from $100 billion in 2022 versus the consensus of $74.13 billion.
The company expects adjusted EPS guidance of $3.25-$3.45, down from $6.58 in 2022 and the consensus of $4.44...Read More
According to data from Benzinga Pro:
- BNTX shares are trading lower by 2.63% to $136.80
- MRNA is lower by 2.69% to $176.00
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
